This inventor holds 1 USPTO granted patent. Top assignee: ETH Zurich. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Oliver Voinnet: Inventor in RNA Research
Introduction
Oliver Voinnet is an inventor based in Zurich, Switzerland, and is associated with ETH Zurich. His patent work concerns methods for purifying functional small RNAs involved in RNA-induced silencing complex (RISC) activity.
Latest Patents
Voinnet is listed as an inventor on 1 patent: “Method and Kit for the Purification of Functional RISC-Associated Small RNAs.” The invention describes methods and kits for purifying functional RISC-associated small RNAs from organisms, organs, tissues, cells, or biological fluids.
Career Highlights
Voinnet’s patent reflects research focused on small RNAs and their association with RISC. The disclosed purification methods and kits are intended to support the isolation of functional molecules from a range of biological sources.
Collaborations
His listed coworkers include Thomas Grentzinger and Grégory Schott. Their names are associated with the collaborative research behind the patent.
Conclusion
Oliver Voinnet’s patent work at ETH Zurich highlights an approach to purifying functional RISC-associated small RNAs for research across diverse biological materials.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
